Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetics study evaluated insulin detemir in subjects with Type 1 diabetes and has completed. The results summarize how the drug is absorbed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin detemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED